(2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
97%
- Product Code: 50419
CAS:
110505-76-5
| Molecular Weight: | 373.36 g./mol | Molecular Formula: | C₁₇H₁₉N₅O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry and sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural similarity to nucleosides, which are essential components of DNA and RNA. It is often explored for its potential antiviral and anticancer properties. Researchers investigate its ability to inhibit viral replication or interfere with cancer cell proliferation by mimicking natural nucleosides, thereby disrupting the synthesis of genetic material in target cells. Additionally, it may serve as a precursor or intermediate in the synthesis of more complex therapeutic agents. Its specific modifications, such as the hydroxybenzyl group, can enhance its binding affinity to biological targets, making it a valuable candidate for drug development. Studies also focus on optimizing its pharmacokinetic properties to improve efficacy and reduce toxicity in potential clinical applications.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Pale yellow powder |
| PURITY | 96.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $190.22 |
+
-
|
| 0.250 | 10-20 days | $246.02 |
+
-
|
| 1.000 | 10-20 days | $594.06 |
+
-
|
(2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural similarity to nucleosides, which are essential components of DNA and RNA. It is often explored for its potential antiviral and anticancer properties. Researchers investigate its ability to inhibit viral replication or interfere with cancer cell proliferation by mimicking natural nucleosides, thereby disrupting the synthesis of genetic material in target cells. Additionally, it may serve as a precursor or intermediate in the synthesis of more complex therapeutic agents. Its specific modifications, such as the hydroxybenzyl group, can enhance its binding affinity to biological targets, making it a valuable candidate for drug development. Studies also focus on optimizing its pharmacokinetic properties to improve efficacy and reduce toxicity in potential clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :